Reitz Christiane
The Taub Institute for Research on Alzheimer's Disease & the Aging Brain, Columbia University, New York, NY, USA and Gertrude H Sergievsky Center, 630 West 168th Street, Columbia University, New York, NY 10032, USA and The Department of Neurology, Columbia University, New York, NY, USA Tel.: +1 212 305 0865; ;
Future Neurol. 2014 Mar;9(2):119-122. doi: 10.2217/fnl.14.1.
The article by Lambert reports the identification of 11 novel susceptibility loci for late-onset Alzheimer's disease. The observations of this study significantly enhance the field since they further disentangle the genetic causes and pathways underlying Alzheimer's disease by identifying novel disease-associated variants clustering in specific pathways. These pathways include APP processing, lipid metabolism, inflammation/immune response, intracellular trafficking/endocytosis, tau metabolism, synaptic function. All of the newly identified disease-associated variants have small effect sizes with increases in risk of 10-20%. The cumulative population attributable fraction associated with known genetic variants amounts now to approximately 80%. This article also underlines the ongoing value of genome-wide association studies for identification of causative common variants in the era of whole-exome and whole-genome sequencing studies.
兰伯特的文章报告了11个新发现的晚发性阿尔茨海默病易感基因座。这项研究的观察结果显著推动了该领域的发展,因为它们通过识别聚集在特定通路中的新的疾病相关变异,进一步厘清了阿尔茨海默病的遗传原因和通路。这些通路包括淀粉样前体蛋白(APP)加工、脂质代谢、炎症/免疫反应、细胞内运输/内吞作用、tau蛋白代谢、突触功能。所有新发现的疾病相关变异的效应大小都较小,风险增加10%-20%。与已知遗传变异相关的累积人群归因分数目前约为80%。本文还强调了在全外显子组和全基因组测序研究时代,全基因组关联研究在识别致病常见变异方面的持续价值。